/PRNewswire/ -- ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today announced that...
null
Oct 21, 2025
www.prnewswire.com
/PRNewswire/ -- ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today announced the...
#Management Changes #Product Stage
Sep 10, 2025
www.prnewswire.com
/PRNewswire/ -- ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today announced the...
#Management Changes #Product Stage
Jun 8, 2017
alzheimersnewstoday.com
Lundbeck Obtains Rights to Research that Targets Immune Checkpoint...
/PRNewswire/ -- ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today announced that...
null
Oct 21, 2025
www.prnewswire.com
/PRNewswire/ -- ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today announced the...
#Management Changes #Product Stage
Sep 10, 2025
www.prnewswire.com
/PRNewswire/ -- ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today announced the...
#Management Changes #Product Stage
Jun 8, 2017
alzheimersnewstoday.com
Lundbeck Obtains Rights to Research that Targets Immune Checkpoint...